Concepedia

Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy

Heng Li, Yucong Zhang, Dong Li, Xin Ma, Kai Xu, Beichen Ding, Hongzhao Li, Zhize Wang, Wei Ouyang, Gongwei Long,

European Urology · 2021 · 37 citations · 23 references

Concepts

MedicineEndocrinologyOncologyGenitourinary OncologyMetastasisMolecular OncologyAndrogen Deprivation TherapyAndrogen PhysiologyAndrogen TherapyHormonal Cancer TherapyHormonal TherapyProstate CancerAndrogen Deprivation Therapy ResistanceAndrogen ResistanceMetastatic Hormone-sensitive Prostate Cancer TherapyProstate Cancer Hormone TherapyReceptor Splice Variants

References

23

Cancer statistics in China, 2015

Wanqing Chen, Rongshou Zheng, Peter D. Baade et al. · CA A Cancer Journal for Clinicians · 2016 · 18K citations · Full text

Medicine, Oncology, Population Health Sciences +17

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

Medicine, Oncology, Cancer Pharmacology +12

Cancer statistics, 2017

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2017 · 15K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

Christopher J. Sweeney, Yu‐Hui Chen, Michael A. Carducci et al. · New England Journal of Medicine · 2015 · 2.8K citations · Full text

Medicine, Oncology, Urology +15

AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer

Emmanuel S. Antonarakis, Changxue Lu, Hao Wang et al. · New England Journal of Medicine · 2014 · 2.7K citations · Full text

Medicine, Oncology, Pharmacology +17